Will Amgen Stock Continue To See Higher Levels Driven By Its

May 8, 2024 · AMGN stock currently trades at 15x forward expected earnings of $19.60 per share (at the mid-point of the company’s provided range), slightly higher than the 14x average over the last five years ...

CouponFollow Extension

$19.60
OFF

Will Amgen Stock Continue To See Higher Levels Driven By Its

1 week from now

forbes.com

$19.60
OFF

Will Amgen Stock Continue To See Higher Levels Driven By Its …

1 week from now

May 9, 2024 · AMGN stock currently trades at 15x forward expected earnings of $19.60 per share (at the mid-point of the company’s provided range), slightly higher than the 14x average over …

nasdaq.com

7%
OFF

What’s Happening With Amgen Stock? - Forbes

1 week from now

4 days ago · Amgen stock (NASDAQ: AMGN) saw a 7% fall on Tuesday, November 12, after an update on the progress with its weight-loss drug — MariTide. An early-stage trial for the drug …

forbes.com

9%
OFF

Will Amgen Stock Continue To See Higher Levels Driven By Its

1 week from now

May 7, 2024 · Amgen stock (NASDAQ: AMGN) has seen a solid 9% rise in a week, outperforming the broader S&amp;P500 index, up 1.5%. The recent rise can be attributed to the …

trefis.com

6%
OFF

Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss …

1 week from now

Jun 4, 2024 · This dividend comes with a five-year CAGR of 9.6% and 12 consecutive annual hikes. Essentially, the company has hiked its dividend every single year since it started paying …

seekingalpha.com

12%
OFF

Why Amgen Stock Zoomed Nearly 12% Higher Today

1 week from now

May 3, 2024 · Market Cap. $175B. Today's Change. (1.05%) $3.37. Current Price. $325.28. Price as of November 8, 2024, 4:00 p.m. ET. The company delivered solid quarterly results, but its …

fool.com

8%
OFF

What's Driving Amgen Stock Higher? - Nasdaq

1 week from now

Sep 8, 2022 12:44AM EDT. Amgen stock (NASDAQ: AMGN) has seen an 8% rise this year, far better than the broader S&P500 index, which is down 18%. However, in the longer term, …

nasdaq.com

16%
OFF

2 Reasons To Buy Amgen Stock, And 1 Reason To Be Cautious

1 week from now

2 days ago · While Amgen's (AMGN-4.16%) shares have underperformed the market over the past 12 months, climbing 19.7% compared to the market's unusually large gain of 35.6%, …

fool.com

40%
OFF

Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With …

1 week from now

Play(7min) Summary. Amgen shares have outperformed IBB by over 40% in the past year, driven higher by a major surge post-earnings in May. With a current price-to-earnings multiple in the …

seekingalpha.com

$2.25
OFF

Amgen Inc. (AMGN) Latest Stock News - Seeking Alpha

1 week from now

Nov 8, 2024 · Amgen declares $2.25 dividend. Get the latest news and real-time alerts from Amgen Inc. (AMGN) stock at Seeking Alpha.

seekingalpha.com

$5.58
OFF

Amgen (AMGN) Stock Price, News & Analysis - MarketBeat

1 week from now

3 days ago · Amgen Inc. (NASDAQ:AMGN) issued its earnings results on Wednesday, October, 30th. The medical research company reported $5.58 earnings per share (EPS) for the quarter, …

marketbeat.com

28%
OFF

Amgen On Pace For Record High Close — Data Talk - Morningstar

1 week from now

Amgen Inc. (AMGN) is currently at $300.35, up $12.33 or 4.28% --Would be new all-time high (Based on available data back to June 17, 1983) --Would be the first record close since Nov. …

morningstar.com

FAQs about Will Amgen Stock Continue To See Higher Levels Driven By Its Coupon?

Is Amgen stock a good stock to buy?

Amgen stock (NASDAQ NDAQ 0.0%: AMGN) has seen a substantial 23% rise this year, far better than the broader S&P500 index, which is down 16%. However, in the longer term, AMGN stock is up 42% from levels seen in late 2018, slightly underperforming the S&P 500 index, up about 65%. ...

Why did Amgen stock fall 7%?

CHINA - 2024/09/17: In this photo illustration, Amgen logo is displayed on a smartphone with a S&P ... [+] index website background. (Photo Illustration by Alvin Chan/SOPA Images/LightRocket via Getty Images) Amgen stock (NASDAQ: AMGN) saw a 7% fall on Tuesday, November 12, after an update on the progress with its weight-loss drug — MariTide. ...

Is Amgen (Amgen) a buy on valuation?

Apply a 17x multiple, still more than four turns cheaper than that of the broader market, and the fair value is closer to $342, making the stock a buy on valuation. Compared to its peers, Amgen sports a soft valuation rating but the earnings picture is attractive given where the stock trades today. ...

Are Amgen insiders buying or selling stock?

In the past three months, Amgen insiders have not sold or bought any company stock. Only 0.69% of the stock of Amgen is held by insiders. 76.50% of the stock of Amgen is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Receive AMGN Stock News and Ratings via Email ...

Why did Amgen reduce its share count?

a 7% reduction in its share count thanks to $15 billion in share repurchases. Amgen’s revenue growth is being driven by its relatively new drugs, including, Repatha, Evenity, Blincyto, and Tezspire, among others. The company’s acquisition of Horizon Therapeutics is also bolstering the top-line growth. ...

Why should you buy Amgen (Amgen)?

So it could target two markets, which is why it's another reason to buy the stock. In short, Amgen is a massive biopharma, with dozens of pipeline programs and a huge portfolio of products on the market. In the third quarter alone, its top line was $8.5 billion, and it reported $5.22 in diluted earnings per share (EPS). ...